In this issue, Emer MacSweeney, a specialist in progressive neurodegenerative and neuro-developmental conditions and traumatic brain injury, believes that we are close to being able to treat the disease the same we currently do with diabetes.
Here, she talks about why the new generation of drugs for Alzheimer’s is important, why caring for people earlier is key and why it might even be not that far away from treating the disease in the same way that diabetes is.
Also in this issue, Alex Adjei, the head of Cleveland Clinic’s Cancer Institute, explains why the fight against cancer is a story of real, measurable progress; Andrew Chadwick-Jones, the chief executive officer of Welbeck Health Partners, talks about the boom in the private healthcare market since Covid; and much more.
We hope you enjoy!
